particles count.

Meet us at the Bio-Europe Spring in Paris, March 23-25.
attyloid

Company profile

attyloid is a biotech spin-off built on strong scientific expertise in the field of protein misfolding and aggregation. We have developed an ultra-sensitive quantitative technology platform with value-adding potential as biomarker of CNS diseases and drug effect assaying, development and QC of biologicals, and counting of viral particles.

 

sFIDA Technology

sFIDA is able to be utilized as a unique biomarker in CNS drug development enabling patient stratification and quantitative measures of target engagement and drug effect. In QC of biologicals and viral particle analysis, sFIDA bridges the present analytical gap in the subvisible range (0.1-10 microns). MORE

attyloid offers its proprietary sFIDA technology for development and quality control of biologicals.

Founders and Idea

Since 2014 our project has been supported by the VIP-Program of the German Federal Ministry of Education. In 2016 we obtained funding by the Helmholtz Enterprise Program and by Start-up NRW to commericalize the sFIDA technolgy as a spin-off company.

attyloid draws on a strong team of founders with expertise in Life Science, Health Care and Corporate Development.

Dr. Oliver Bannach

Dr. Oliver Bannach

CEO

 Dr. Andreas Kulawik

Dr. Andreas Kulawik

COO

Dr. Christian Zafiu

Dr. Christian Zafiu

CSO

Prof. em. Dr. Dr. h.c. Detlev Riesner

Prof. em. Dr. Dr. h.c. Detlev Riesner

Supervisory Board

Prof. Dr. Dieter Willbold

Prof. Dr. Dieter Willbold

Supervisory Board Chairman

Get in Touch

Privacy Policy*

4 + 12 =

attyloid GmbH
Elsa-Brändström-Str. 34
40595 Düsseldorf
Germany

Mail: info@attyloid.com

Fon: +49 (0) 211 81-10377

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help.

Select an option to continue

Your selection was saved!

Help

Help

To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set.

You can change your cookie setting here anytime: Privacy Policy. Legal Notice

Back